May 15, 2007 — Edwards Lifesciences Corp. announced last week that its subsidiary, Edwards Lifesciences PVT, Inc., has filed a patent infringement lawsuit against CoreValve Inc., of Irvine, Calif., in the District Court of Dusseldorf, Germany. The suit seeks relief for alleged infringement of a patent for transcatheter heart valve technology.

May 15, 2007 — St. Jude Medical Inc. announced last week an expanded European CE Mark approval to include the Therapy Cool Path irrigated ablation catheter with bi-directional steering for use in ablation procedures to treat abnormal heart rhythms.

This catheter is the first open-irrigated ablation catheter to provide bi-directional steering, a feature designed to help physicians maneuver the catheter in difficult areas of the heart and perform complex ablations more efficiently.

May 15, 2007 — Siemens has announced the latest innovation in electrophysiology (EP) solutions with the introduction of syngo DynaCT Cardiac, which enables 3D imaging comparable to computed tomography (CT) in the EP lab during procedures.

May 14, 2007 — More than 25 leading heart advocacy groups have joined to form the Sudden Cardiac Arrest (SCA) Coalition – the very first coalition dedicated to advancing increased research, awareness and educational efforts to address the nation’s number one cardiovascular killer. The Coalition, announced as part of Heart Rhythm 2007, the Society’s 28th Annual Scientific Sessions, will urge Congress and the federal agencies involved in national health policies and programs, to devote more resources to greater public awareness of SCA, research and access to life-saving therapies.

May 14, 2007 — Two renowned experts debated the role of PCI and coronary artery bypass grafting (CABG) for the treatment of patients with left main coronary artery disease during the Annual Scientific Sessions of the Society for Cardiovascular Angiography and Interventions (SCAI) last week in Orlando, FL.

May 11, 2007 — Northwestern University in Chicago has published results of a one-year study of roughly 5,500 patients who underwent angioplasty for the insertion of drug-eluting stents (DES) — it was found that nearly half of those patients did not fit the standard, approved indications for use set by the FDA.

May 11, 2007 — St. Jude Medical Inc. has announced FDA approval of its new OptiSense lead, a first-of-its-kind "smart" pacing lead designed to offer more accurate sensing in the upper chamber of the heart (right atrium).

May 9, 2007 — Biosense Webster today announced commercial availability of its EZ Steer NAV Bi-Directional Catheter, indicated for use with the Carto XP System, a unique navigational system that provides real-time feedback in guiding the catheter to the target.

The defining feature of the new bi-directional navigational catheter is its patented micro-tensioning system, which enables physicians, through a series of very small, continuous micro-movements, to progressively dial in the precise force desired for deflection of the catheter.

May 9, 2007 — Biosense Webster Inc., a worldwide leader in cardiac mapping and ablation, and Medtronic Inc., world leader in implanted cardiac rhythm devices, have announced plans to collaborate on a clinical trial, educational initiatives and a product development program, all of which are aimed at advancing the care of patients with cardiac arrhythmias, also known as irregular heartbeats.

May 9, 2007 — Allied Minds, an investment corporation specializing in early stage university business ventures, has teamed with the University of Colorado to establish Illumasonix LLC, a start-up company that is developing a noninvasive method to provide quantitative information on complex blood flow in the treatment of vascular disease.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now